Search clinical trials for: Rimeporide
Total 1 results
-
EspeRare FoundationCompletedMuscular Dystrophy, DuchenneItaly, France, Spain, United Kingdom
Sponsors and Collaborators
- Fogarty International Center of the National Institute of Health
- Pedro Gamito
- Hospital Samaritano Paulista
- Advanced Life Solutions
- Dr. Praveen B.H
- Universitatea de Medicina si Farmacie Iuliu Hatieganu
- The Fred Hollows Foundation, Australia
- Stannah Stairlifts
- Prof. Jacques SCHRENZEL
- UZ Leuven, campus Pellenberg (Belgium)
- Physip S.A
- Markham Stouffville Hospital
- Custom Pharmaceuticals Limited
- Braunschweig Integrated Centre of Systems Biology (BRICS), Germany
- IN-JET APS
- Familien Hede Nielsens Fond
- JMI Laboratories
- Janssen (China) Research & Development Center
- Hazelden Betty Ford Foundation
- Nestlé Health Science Belgium
- View Full List
Medical Conditions
- Skull Base Neoplasms
- Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Chronic Phase
- Epidemic Hemorrhagic Fever
- Predictors of Atrial Fibrillation Recurrences
- Childhood Langerhans Cell Histiocytosis
- Endocarditis Infective
- Tay-Sachs Disease Ganglioside
- Gullian Barre Syndrome
- Painless Hysteroscopy
- Fetus or Neonate Affected by External Version Before Labor
- Multisystem Proteinopathy
- Closure; Foramen Ovale
- Pulmonary Adenocarcinoma
- Chlamydophila Infections
- Cancers of Non-thoracic Origin With Metastases to the Lungs or Pleura
- Ewing's Family Tumors
- Cutaneous Leiomyomata With Uterine Leiomyomata
- Fracture Dislocation of Cervical Spine
- Psoriasis, Arthritic
- Spine Surgeries
- View Full List
Drug Interventions
- Azelastine hydrochloride (BAYR9258)
- Vehicle
- Adapalene Gel 0.3%
- Adriamycin
- NanoDoce (intravesical instillation) - Induction and Maintenance Instillations
- PET/CT using PET ligands [F-18]FDG and [F-18]DPA-714
- Esomeprazole 40mg before
- Neihulizumab
- Chemotherapeutic Agent
- Palliative care group first-line scheme
- Qingkailing injection 40 ml
- Glimepiride
- High dose pantoprazole infusion
- Mocetinostat - Recommended Phase 2 Dose (70 mg)
- Naltrexone 50 mg/day + Cognitive Behavioral Therapy
- Redifferentiation with retinoid acid
- EFV +TVA
- Estradiol+Drospirenone
- Cereport
- Semapimod
- View Full List
CROs by country
- Contract Research Organizations in Finland
- Contract Research Organizations in Gambia
- Contract Research Organizations in Kazakhstan
- Contract Research Organizations in Kenya
- Contract Research Organizations in Mexico
- Contract Research Organizations in Moldova
- Contract Research Organizations in Morocco
- Contract Research Organizations in Netherlands
- Contract Research Organizations in Qatar
- Contract Research Organizations in South Korea
- Contract Research Organizations in Thailand
- Contract Research Organizations in Tunisia
- Contract Research Organizations in Uruguay
- CRO list by country